Items Tagged ‘Dr. David Knopman’

Mayo Clinic in the News Weekly Highlights for April 19, 2019

April 19, 2019

Mayo Clinic in the News Weekly Highlights for April 19, 2019

By Emily Blahnik Emily Blahnik

Washington Post, CTE researchers discover possible step toward diagnostic test for living patients by Jacob Bogage — Medical researchers have made what they cautiously characterized as a possible first step toward diagnosing the neurodegenerative illness chronic traumatic encephalopathy (CTE) in living patients, according to an article published Wednesday in the New England Journal of Medicine. […]

View full entry

Tags: A.L.S., aging, arthritis, Ashley Schmitt, Aspirin, Breast Cancer, burnout, cannabis, carillon, Cathy Fraser, Christie Vogel, Cris Ross


April 18, 2019

More Alzheimer’s drug trial failures: Are researchers on the wrong track?

By Karl Oestreich Karl Oestreich

HealthDayby Dennis Thompson Researchers pulled the plug early on the latest failed clinical trial, after patients’ brain power continued to decline even though the amyloid beta blocker verubecestat successfully lowered amyloid levels in their brains and spinal fluid. The disappointing verubecestat results appear in the April 11 issue of the New England Journal of Medicine, […]

View full entry

Tags: alzheimer's disease, Dr. David Knopman, drug trials, HealthDay


April 5, 2019

Mayo Clinic in the News Weekly Highlights for April 5, 2019

By Emily Blahnik Emily Blahnik

Wall Street Journal, What AI Can Tell From Listening to You by John McCormick — The Mayo Clinic conducted a two-year study that ended in February 2017 to see if voice analysis was capable of detecting coronary-artery disease. Every person’s voice has different frequencies that can be analyzed, explains Amir Lerman, director of the Cardiovascular […]

View full entry

Tags: acoustic neuroma, AI, Allie Metzler, alzheimer's disease, artificial Intelligence, back pain, Beth Dittbenner, Beyond Verbal, BIOMEX, brain tumor, breast cancer screening, Breath Diagnostics


March 29, 2019

Mayo Clinic in the News Weekly Highlights for March 29, 2019

By Emily Blahnik Emily Blahnik

Reuters, Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value by Julie Steenhuysen — Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease drug aducanumab, a major setback in the quest to find a treatment for the mind-wasting disease and a blow to Biogen, […]

View full entry

Tags: AliveCor, alzheimer's disease, anal cancer, artificial Intelligence, Biogen, blood donation, Blood Donor Program, caffeine, cognitive decline, dementia, depression, Derrick Rose


August 31, 2018

Mayo Clinic in the News Weekly Highlights for August 31, 2018

By Emily Blahnik Emily Blahnik

Los Angeles Times, Noise causes stress. Here’s why you need to seek out some silence by Alene Dawson — It’s a noisy planet. So much so that research calls noise pollution a “modern plague” and a threat to our health and well-being. “Noisy, chaotic environments increase stress levels, and chronic stress has been shown to… […]

View full entry

Tags: alzheimer's disease, Alzheimer’s walk, art center, arthritis, ASU, Austin Ferguson, Bradley Prigge, breast milk, carillon, clay, Dan Gaz, Diversity


August 10, 2018

Mayo Clinic in the News Weekly Highlights for August 10, 2018

By Emily DeBoom Emily DeBoom

NBC News, How to keep yourself (and your dog) cool in a heatwave by Vivian Manning-Schaffel — Thanks to climate change, summers are longer and hotter, and we only have more extreme vacillations in temperature to look forward to… The most serious heat-related illness, heatstroke is described by The Mayo Clinic as the body “overheating […]

View full entry

Tags: 1883 Rochester, ablation, addiction, alzheimer's disease, beer belly, Beyoncé, Chemotherapy, childbirth, Clostridium difficile infection, CTE, dementia, destination medical center


July 27, 2018

Mayo Clinic in the News Weekly Highlights for July 27, 2018

By Emily Blahnik Emily Blahnik

STAT, Experimental Alzheimer’s drug significantly slowed patients’ cognitive decline, buoying hopes for treatment by Damian Garde — The Phase 2 trial, which employed multiple statistical measures, failed its primary goal. Four doses of BAN2401 didn’t outperform placebo, and the high dose was tested on just 161 patients. Furthermore, the metric Biogen and Eisai used to […]

View full entry

Tags: alzheimer's disease, amgen, anesthesia, Big Blue Dragon Boat Race, bioethics, brain freeze, BRCA gene, Cancer, dementia, Dr. Amaal Starling, Dr. Amit Sood, Dr. Asad Javed.


July 13, 2018

Mayo Clinic in the News Weekly Highlights for July 9, 2018

By Emily Blahnik Emily Blahnik

        Wall Street Journal, New Effort for Lyme Disease Vaccine Draws Early Fire by Sumathi Reddy — Gregory Poland, director of the vaccine research group at Mayo Clinic in Rochester, Minn., published a 2011 study in the journal Clinical Infectious Diseases detailing what happened with the previous Lyme vaccine and lessons learned […]

View full entry

Tags: age-related disease, alzheimer's disease, Angie Murad, artificial Intelligence, asthma exacerbation, Biogen, Career Immersion Program, cervical cancer, Darla Lytle, dementia, Diversity, Dr Felipe Sierra


March 23, 2018

Mayo Clinic in the News Weekly Highlights for March 23, 2018

By Emily Blahnik Emily Blahnik

      USA Today, ‘Highly fit’ middle-age women nearly 90% less likely to develop dementia decades later, study finds by Karen Weintraub — Maintaining a healthy lifestyle in mid-life, decades before disease sets in, makes sense, said David Knopman, a fellow of the American Academy of Neurology, who was not involved in the study. […]

View full entry

Tags: 3D printing, A.L.S., affordable housing, allergies, alzheimer's disease, Amber Kohnhorst, arthritis, asthma, autism, Bailey Sevier, Billy Gillispie, blood donation


March 16, 2018

Mayo Clinic in the News Weekly Highlights for March 16, 2018

By Emily Blahnik Emily Blahnik

      New York Times, Black Cancer Matters by Susan Gubar — Given the mortality discrepancies, it is disturbing that African-Americans are underrepresented as subjects in cancer research, as are other minorities. According to research by Dr. Narjust Duma of the Mayo Clinic, only 6 percent of participants in clinical trials are black, although […]

View full entry

Tags: A.L.S., angel gowns, anxiety, Bill Schluter, Breast Cancer, Cancer, Daylight Savings Time, dementia, diarrhea, Dr. Alfredo Quinones-Hinojosa, Dr. Angela Lunde, Dr. Barry Borlaug


Contact Us · Privacy Policy